Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 173 entries
Sorted by: Best Match Show Resources per page
[Children's life conditions must be improved].

Ugeskrift for laeger

Jespersen I.
PMID: 2595839
Ugeskr Laeger. 1989 Nov 20;151(47):3137.

No abstract available.

Cite
Jespersen I. Børns levevilkår må forbedres. [Children's life conditions must be improved]. Ugeskr Laeger. 1989;151(47):3137
Jespersen, I. (1989). Børns levevilkår må forbedres. [Children's life conditions must be improved]. Ugeskrift for laeger, 151(47), 3137.
Jespersen, I. "Børns levevilkår må forbedres." [Children's life conditions must be improved]. Ugeskrift for laeger vol. 151,47 (1989): 3137.
Jespersen I. Børns levevilkår må forbedres. [Children's life conditions must be improved]. Ugeskr Laeger. 1989 Nov 20;151(47):3137. Danish. PMID: 2595839.
Copy Download .nbib Format: NLM
Corrigendum to "Review - Mitochondria-rich cells as experimental model in studies of epithelial chloride channels" [Biochim. Biophys. Acta 1566 (2002) 28-43].

Biochimica et biophysica acta

Willumsen NJ, Amstrup J, Møbjerg N, Jespersen Å, Kristensen P, Larsen EH.
PMID: 27289423
Biochim Biophys Acta. 2016 Sep;1858(9):2245-2246. doi: 10.1016/j.bbamem.2016.05.017. Epub 2016 Jun 09.

No abstract available.

Cite
Willumsen NJ, Amstrup J, Møbjerg N, et al. Corrigendum to "Review - Mitochondria-rich cells as experimental model in studies of epithelial chloride channels" [Biochim. Biophys. Acta 1566 (2002) 28-43]. Biochim Biophys Acta. 2016;1858(9):2245-2246doi: 10.1016/j.bbamem.2016.05.017.
Willumsen, N. J., Amstrup, J., Møbjerg, N., Jespersen, �. �., Kristensen, P., & Larsen, E. H. (2016). Corrigendum to "Review - Mitochondria-rich cells as experimental model in studies of epithelial chloride channels" [Biochim. Biophys. Acta 1566 (2002) 28-43]. Biochimica et biophysica acta, 1858(9), 2245-2246. https://doi.org/10.1016/j.bbamem.2016.05.017
Willumsen, Niels J, et al. "Corrigendum to "Review - Mitochondria-rich cells as experimental model in studies of epithelial chloride channels" [Biochim. Biophys. Acta 1566 (2002) 28-43]." Biochimica et biophysica acta vol. 1858,9 (2016): 2245-2246. doi: https://doi.org/10.1016/j.bbamem.2016.05.017
Willumsen NJ, Amstrup J, Møbjerg N, Jespersen Å, Kristensen P, Larsen EH. Corrigendum to "Review - Mitochondria-rich cells as experimental model in studies of epithelial chloride channels" [Biochim. Biophys. Acta 1566 (2002) 28-43]. Biochim Biophys Acta. 2016 Sep;1858(9):2245-2246. doi: 10.1016/j.bbamem.2016.05.017. Epub 2016 Jun 09. PMID: 27289423.
Copy Download .nbib Format: NLM
Exponential protection of zero modes in Majorana islands.

Nature

Albrecht SM, Higginbotham AP, Madsen M, Kuemmeth F, Jespersen TS, Nygård J, Krogstrup P, Marcus CM.
PMID: 26961654
Nature. 2016 Mar 10;531(7593):206-9. doi: 10.1038/nature17162.

Majorana zero modes are quasiparticle excitations in condensed matter systems that have been proposed as building blocks of fault-tolerant quantum computers. They are expected to exhibit non-Abelian particle statistics, in contrast to the usual statistics of fermions and bosons,...

Cite
Albrecht SM, Higginbotham AP, Madsen M, et al. Exponential protection of zero modes in Majorana islands. Nature. 2016;531(7593):206-9doi: 10.1038/nature17162.
Albrecht, S. M., Higginbotham, A. P., Madsen, M., Kuemmeth, F., Jespersen, T. S., Nygård, J., Krogstrup, P., & Marcus, C. M. (2016). Exponential protection of zero modes in Majorana islands. Nature, 531(7593), 206-9. https://doi.org/10.1038/nature17162
Albrecht, S M, et al. "Exponential protection of zero modes in Majorana islands." Nature vol. 531,7593 (2016): 206-9. doi: https://doi.org/10.1038/nature17162
Albrecht SM, Higginbotham AP, Madsen M, Kuemmeth F, Jespersen TS, Nygård J, Krogstrup P, Marcus CM. Exponential protection of zero modes in Majorana islands. Nature. 2016 Mar 10;531(7593):206-9. doi: 10.1038/nature17162. PMID: 26961654.
Copy Download .nbib Format: NLM
Methylprednisolone Pulse Treatment of Graves' Ophthalmopathy Is Not Associated with Secondary Adrenocortical Insufficiency.

European thyroid journal

Jespersen S, Nygaard B, Kristensen LØ.
PMID: 26835424
Eur Thyroid J. 2015 Dec;4(4):222-5. doi: 10.1159/000440834. Epub 2015 Oct 27.

OBJECTIVE: Graves' ophthalmopathy (GO) is an inflammatory disease in the orbital region. The first-line medical treatment is glucocorticoids. An important potential side effect of glucocorticoid treatment is suppression of the hypothalamic-pituitary-adrenal (HPA) axis with impairment of endogenous cortisol production,...

Cite
Jespersen S, Nygaard B, Kristensen LØ. Methylprednisolone Pulse Treatment of Graves' Ophthalmopathy Is Not Associated with Secondary Adrenocortical Insufficiency. Eur Thyroid J. 2015;4(4):222-5doi: 10.1159/000440834.
Jespersen, S., Nygaard, B., & Kristensen, L. �. �. (2015). Methylprednisolone Pulse Treatment of Graves' Ophthalmopathy Is Not Associated with Secondary Adrenocortical Insufficiency. European thyroid journal, 4(4), 222-5. https://doi.org/10.1159/000440834
Jespersen, Sofie, et al. "Methylprednisolone Pulse Treatment of Graves' Ophthalmopathy Is Not Associated with Secondary Adrenocortical Insufficiency." European thyroid journal vol. 4,4 (2015): 222-5. doi: https://doi.org/10.1159/000440834
Jespersen S, Nygaard B, Kristensen LØ. Methylprednisolone Pulse Treatment of Graves' Ophthalmopathy Is Not Associated with Secondary Adrenocortical Insufficiency. Eur Thyroid J. 2015 Dec;4(4):222-5. doi: 10.1159/000440834. Epub 2015 Oct 27. PMID: 26835424; PMCID: PMC4716422.
Copy Download .nbib Format: NLM
Preserving residual renal function in dialysis patients: an update on evidence to assist clinical decision making.

NDT plus

Kjaergaard KD, Jensen JD, Peters CD, Jespersen B.
PMID: 25949486
NDT Plus. 2011 Aug;4(4):225-30. doi: 10.1093/ndtplus/sfr035. Epub 2011 Apr 04.

It has been documented that preservation of residual renal function in dialysis patients improves quality of life as well as survival. Clinical trials on strategies to preserve residual renal function are clearly lacking. While waiting for more results from...

Cite
Kjaergaard KD, Jensen JD, Peters CD, et al. Preserving residual renal function in dialysis patients: an update on evidence to assist clinical decision making. NDT Plus. 2011;4(4):225-30doi: 10.1093/ndtplus/sfr035.
Kjaergaard, K. D., Jensen, J. D., Peters, C. D., & Jespersen, B. (2011). Preserving residual renal function in dialysis patients: an update on evidence to assist clinical decision making. NDT plus, 4(4), 225-30. https://doi.org/10.1093/ndtplus/sfr035
Kjaergaard, Krista Dybtved, et al. "Preserving residual renal function in dialysis patients: an update on evidence to assist clinical decision making." NDT plus vol. 4,4 (2011): 225-30. doi: https://doi.org/10.1093/ndtplus/sfr035
Kjaergaard KD, Jensen JD, Peters CD, Jespersen B. Preserving residual renal function in dialysis patients: an update on evidence to assist clinical decision making. NDT Plus. 2011 Aug;4(4):225-30. doi: 10.1093/ndtplus/sfr035. Epub 2011 Apr 04. PMID: 25949486; PMCID: PMC4421450.
Copy Download .nbib Format: NLM
Influenza virus vaccination and kidney graft rejection: causality or coincidence.

Clinical kidney journal

Fischer AS, Møller BK, Krag S, Jespersen B, Hewett JP.
PMID: 26034595
Clin Kidney J. 2015 Jun;8(3):325-8. doi: 10.1093/ckj/sfv027. Epub 2015 May 06.

Influenza can cause significant morbidity and mortality in renal transplant recipients especially with a high rate of lower respiratory disease. Annual influenza vaccination is therefore recommended to renal transplant recipients. We report the first three cases of acute kidney...

Cite
Fischer AS, Møller BK, Krag S, et al. Influenza virus vaccination and kidney graft rejection: causality or coincidence. Clin Kidney J. 2015;8(3):325-8doi: 10.1093/ckj/sfv027.
Fischer, A. S., Møller, B. K., Krag, S., Jespersen, B., & Hewett, J. P. (2015). Influenza virus vaccination and kidney graft rejection: causality or coincidence. Clinical kidney journal, 8(3), 325-8. https://doi.org/10.1093/ckj/sfv027
Fischer, Anne Sophie Lind, et al. "Influenza virus vaccination and kidney graft rejection: causality or coincidence." Clinical kidney journal vol. 8,3 (2015): 325-8. doi: https://doi.org/10.1093/ckj/sfv027
Fischer AS, Møller BK, Krag S, Jespersen B, Hewett JP. Influenza virus vaccination and kidney graft rejection: causality or coincidence. Clin Kidney J. 2015 Jun;8(3):325-8. doi: 10.1093/ckj/sfv027. Epub 2015 May 06. PMID: 26034595; PMCID: PMC4440474.
Copy Download .nbib Format: NLM
Giant fluctuations and gate control of the g-factor in InAs nanowire quantum dots.

Nano letters

Csonka S, Hofstetter L, Freitag F, Oberholzer S, Schönenberger C, Jespersen TS, Aagesen M, Nygård J.
PMID: 18937519
Nano Lett. 2008 Nov;8(11):3932-5. doi: 10.1021/nl802418w. Epub 2008 Oct 21.

We study the g-factor of discrete electron states in InAs nanowire based quantum dots. The g values are determined from the magnetic field splitting of the zero bias anomaly due to the spin 1/2 Kondo effect. Unlike to previous...

Cite
Csonka S, Hofstetter L, Freitag F, et al. Giant fluctuations and gate control of the g-factor in InAs nanowire quantum dots. Nano Lett. 2008;8(11):3932-5doi: 10.1021/nl802418w.
Csonka, S., Hofstetter, L., Freitag, F., Oberholzer, S., Schönenberger, C., Jespersen, T. S., Aagesen, M., & Nygård, J. (2008). Giant fluctuations and gate control of the g-factor in InAs nanowire quantum dots. Nano letters, 8(11), 3932-5. https://doi.org/10.1021/nl802418w
Csonka, S, et al. "Giant fluctuations and gate control of the g-factor in InAs nanowire quantum dots." Nano letters vol. 8,11 (2008): 3932-5. doi: https://doi.org/10.1021/nl802418w
Csonka S, Hofstetter L, Freitag F, Oberholzer S, Schönenberger C, Jespersen TS, Aagesen M, Nygård J. Giant fluctuations and gate control of the g-factor in InAs nanowire quantum dots. Nano Lett. 2008 Nov;8(11):3932-5. doi: 10.1021/nl802418w. Epub 2008 Oct 21. PMID: 18937519.
Copy Download .nbib Format: NLM
A 158 fs 5.3 nJ fiber-laser system at 1 microm using photonic bandgap fibers for dispersion control and pulse compression.

Optics express

Nielsen CK, Jespersen KG, Keiding SR.
PMID: 19516777
Opt Express. 2006 Jun 26;14(13):6063-8. doi: 10.1364/oe.14.006063.

We demonstrate a 158 fs 5.3 nJ mode-locked laser system based on a fiber oscillator, fiber amplifier and fiber compressor. Dispersion compensation in the fiber oscillator was obtained with a solid-core photonic bandgap (SC-PBG) fiber spliced to standard fibers,...

Cite
Nielsen CK, Jespersen KG, Keiding SR. A 158 fs 5.3 nJ fiber-laser system at 1 microm using photonic bandgap fibers for dispersion control and pulse compression. Opt Express. 2006;14(13):6063-8doi: 10.1364/oe.14.006063.
Nielsen, C. K., Jespersen, K. G., & Keiding, S. R. (2006). A 158 fs 5.3 nJ fiber-laser system at 1 microm using photonic bandgap fibers for dispersion control and pulse compression. Optics express, 14(13), 6063-8. https://doi.org/10.1364/oe.14.006063
Nielsen, C K, et al. "A 158 fs 5.3 nJ fiber-laser system at 1 microm using photonic bandgap fibers for dispersion control and pulse compression." Optics express vol. 14,13 (2006): 6063-8. doi: https://doi.org/10.1364/oe.14.006063
Nielsen CK, Jespersen KG, Keiding SR. A 158 fs 5.3 nJ fiber-laser system at 1 microm using photonic bandgap fibers for dispersion control and pulse compression. Opt Express. 2006 Jun 26;14(13):6063-8. doi: 10.1364/oe.14.006063. PMID: 19516777.
Copy Download .nbib Format: NLM
Identification of risk factors for vascular thrombosis may reduce early renal graft loss: a review of recent literature.

Journal of transplantation

Keller AK, Jorgensen TM, Jespersen B.
PMID: 22701162
J Transplant. 2012;2012:793461. doi: 10.1155/2012/793461. Epub 2012 May 31.

Renal graft survival has improved over the past years, mainly owing to better immunosuppression. Vascular thrombosis, though rare, therefore accounts for up to one third of early graft loss. We assess current literature on transplantation, identify thrombosis risk factors,...

Cite
Keller AK, Jorgensen TM, Jespersen B. Identification of risk factors for vascular thrombosis may reduce early renal graft loss: a review of recent literature. J Transplant. 2012;2012:793461doi: 10.1155/2012/793461.
Keller, A. K., Jorgensen, T. M., & Jespersen, B. (2012). Identification of risk factors for vascular thrombosis may reduce early renal graft loss: a review of recent literature. Journal of transplantation, 2012793461. https://doi.org/10.1155/2012/793461
Keller, Anna Krarup, et al. "Identification of risk factors for vascular thrombosis may reduce early renal graft loss: a review of recent literature." Journal of transplantation vol. 2012 (2012): 793461. doi: https://doi.org/10.1155/2012/793461
Keller AK, Jorgensen TM, Jespersen B. Identification of risk factors for vascular thrombosis may reduce early renal graft loss: a review of recent literature. J Transplant. 2012;2012:793461. doi: 10.1155/2012/793461. Epub 2012 May 31. PMID: 22701162; PMCID: PMC3369524.
Copy Download .nbib Format: NLM
Draft Whole-Genome Sequence of Bacillus sonorensis Strain L12, a Source of Nonribosomal Lipopeptides.

Genome announcements

Adimpong DB, Sørensen KI, Nielsen DS, Thorsen L, Rasmussen TB, Derkx PM, Jespersen L.
PMID: 23538904
Genome Announc. 2013 Mar 28;1(2):e0009713. doi: 10.1128/genomeA.00097-13.

The Bacillus sonorensis L12 draft genome sequence is approximately 4,647,754 bp in size with a G+C content of 45.2%. Over 86% of the genome contains protein-encoding genes, including several gene clusters for de novo biosynthesis of the nonribosomal lipopeptides...

Cite
Adimpong DB, Sørensen KI, Nielsen DS, et al. Draft Whole-Genome Sequence of Bacillus sonorensis Strain L12, a Source of Nonribosomal Lipopeptides. Genome Announc. 2013;1(2):e0009713doi: 10.1128/genomeA.00097-13.
Adimpong, D. B., Sørensen, K. I., Nielsen, D. S., Thorsen, L., Rasmussen, T. B., Derkx, P. M., & Jespersen, L. (2013). Draft Whole-Genome Sequence of Bacillus sonorensis Strain L12, a Source of Nonribosomal Lipopeptides. Genome announcements, 1(2), e0009713. https://doi.org/10.1128/genomeA.00097-13
Adimpong, David B, et al. "Draft Whole-Genome Sequence of Bacillus sonorensis Strain L12, a Source of Nonribosomal Lipopeptides." Genome announcements vol. 1,2 (2013): e0009713. doi: https://doi.org/10.1128/genomeA.00097-13
Adimpong DB, Sørensen KI, Nielsen DS, Thorsen L, Rasmussen TB, Derkx PM, Jespersen L. Draft Whole-Genome Sequence of Bacillus sonorensis Strain L12, a Source of Nonribosomal Lipopeptides. Genome Announc. 2013 Mar 28;1(2):e0009713. doi: 10.1128/genomeA.00097-13. PMID: 23538904; PMCID: PMC3622994.
Copy Download .nbib Format: NLM
Debaryomyces hansenii strains differ in their production of flavor compounds in a cheese-surface model.

MicrobiologyOpen

Gori K, Sørensen LM, Petersen MA, Jespersen L, Arneborg N.
PMID: 22950022
Microbiologyopen. 2012 Jun;1(2):161-8. doi: 10.1002/mbo3.11.

Flavor production among 12 strains of Debaryomyces hansenii when grown on a simple cheese model mimicking a cheese surface was investigated by dynamic headspace sampling followed by gas chromatography-mass spectrometry. The present study confirmed that D. hansenii possess the...

Cite
Gori K, Sørensen LM, Petersen MA, et al. Debaryomyces hansenii strains differ in their production of flavor compounds in a cheese-surface model. Microbiologyopen. 2012;1(2):161-8doi: 10.1002/mbo3.11.
Gori, K., Sørensen, L. M., Petersen, M. A., Jespersen, L., & Arneborg, N. (2012). Debaryomyces hansenii strains differ in their production of flavor compounds in a cheese-surface model. MicrobiologyOpen, 1(2), 161-8. https://doi.org/10.1002/mbo3.11
Gori, Klaus, et al. "Debaryomyces hansenii strains differ in their production of flavor compounds in a cheese-surface model." MicrobiologyOpen vol. 1,2 (2012): 161-8. doi: https://doi.org/10.1002/mbo3.11
Gori K, Sørensen LM, Petersen MA, Jespersen L, Arneborg N. Debaryomyces hansenii strains differ in their production of flavor compounds in a cheese-surface model. Microbiologyopen. 2012 Jun;1(2):161-8. doi: 10.1002/mbo3.11. PMID: 22950022; PMCID: PMC3426413.
Copy Download .nbib Format: NLM
Potential of Pectins to Beneficially Modulate the Gut Microbiota Depends on Their Structural Properties.

Frontiers in microbiology

Larsen N, Bussolo de Souza C, Krych L, Barbosa Cahú T, Wiese M, Kot W, Hansen KM, Blennow A, Venema K, Jespersen L.
PMID: 30828323
Front Microbiol. 2019 Feb 15;10:223. doi: 10.3389/fmicb.2019.00223. eCollection 2019.

Pectins are plant cell-wall polysaccharides which can be utilized by commensal bacteria in the gut, exhibiting beneficial properties for the host. Knowledge of the impact of pectins on intestinal bacterial communities is insufficient and limited to a few types...

Cite
Larsen N, Bussolo de Souza C, Krych L, et al. Potential of Pectins to Beneficially Modulate the Gut Microbiota Depends on Their Structural Properties. Front Microbiol. 2019;10:223doi: 10.3389/fmicb.2019.00223.
Larsen, N., Bussolo de Souza, C., Krych, L., Barbosa Cahú, T., Wiese, M., Kot, W., Hansen, K. M., Blennow, A., Venema, K., & Jespersen, L. (2019). Potential of Pectins to Beneficially Modulate the Gut Microbiota Depends on Their Structural Properties. Frontiers in microbiology, 10223. https://doi.org/10.3389/fmicb.2019.00223
Larsen, Nadja, et al. "Potential of Pectins to Beneficially Modulate the Gut Microbiota Depends on Their Structural Properties." Frontiers in microbiology vol. 10 (2019): 223. doi: https://doi.org/10.3389/fmicb.2019.00223
Larsen N, Bussolo de Souza C, Krych L, Barbosa Cahú T, Wiese M, Kot W, Hansen KM, Blennow A, Venema K, Jespersen L. Potential of Pectins to Beneficially Modulate the Gut Microbiota Depends on Their Structural Properties. Front Microbiol. 2019 Feb 15;10:223. doi: 10.3389/fmicb.2019.00223. eCollection 2019. PMID: 30828323; PMCID: PMC6384267.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 173 entries